CORC  > 中国医学科学院 北京协和医学院
Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2(V617F) against myeloproliferative neoplasms
Hu, Min; Xu, Chengbo; Yang, Chao; Zuo, Hongli; Chen, Chengjuan; Zhang, Dan; Shi, Gaona; Wang, Wenjie; Shi, Jiangong; Zhang, Tiantai
2019
卷号38期号:1页码:49
关键词JAK2(V617F) JAK2 inhibitor Myeloproliferative neoplasms Apoptosis ZT55
ISSN号1756-9966
DOI10.1186/s13046-019-1062-x
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6345023
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Hu, Min,Xu, Chengbo,Yang, Chao,et al. Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2(V617F) against myeloproliferative neoplasms[J],2019,38(1):49.
APA Hu, Min.,Xu, Chengbo.,Yang, Chao.,Zuo, Hongli.,Chen, Chengjuan.,...&Zhang, Tiantai.(2019).Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2(V617F) against myeloproliferative neoplasms.,38(1),49.
MLA Hu, Min,et al."Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2(V617F) against myeloproliferative neoplasms".38.1(2019):49.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace